Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Goserelin implants vs microspheres in prostate cancer
ChiCTR2500097187Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Feb 2025
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of goserelin in prostate cancer (PCa) (2 cohorts), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: Change in mean serum testosterone from baseline and Change in mean serum PSA from baseline. Started Feb 2025; status: recruiting.
02
Drugs
goserelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on ChiCTR2500097187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500097187.